生晶藥廠BCRX

那斯達克 · USD
7.95
-0.19
(-2.33%)
收盤 08/02 03:59 (UTC+8)
盤後 
8.05 
+0.10 
(+1.26%)
08/02 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.80
  • 0.69
  • 0.82
  • 0.87
  • 0.93
  • 0.93
  • 1.09
  • 1.17
  • 1.32
  • 1.46
icon
  • 4.90
  • -13.54
  • 19.94
  • 5.15
  • 7.68
  • -0.69
  • 17.86
  • 7.09
  • 12.34
  • 10.64
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
145,534
131,534
117,085
109,332
92,761
93,401
86,742
82,491
68,778
79,545
營業成本
4,5686,0943,2111,6991,2651,5571,0998949312,383
營業毛利
140,966
125,440
113,874
107,633
91,496
91,844
85,643
81,597
67,847
77,162
營業費用
119,739-106,182--134,51497,564102,30096,262123,473
研發費用
37,27049,44141,08137,62346,49370,05246,87951,24748,38873,207
推銷及管理費用
82,46980,47065,08461,08759,36464,38250,64850,99747,86750,153
非經常性項目費用
-37171621278037567113
其他營業費用
----------
營業利益
21,227
-4,508
7,692
8,761
-14,488
-42,670
-11,921
-20,703
-28,415
-46,311
其他收入及費用
3,0252,9663,6893,4703,9804,0913,447-24,9683,1491,304
利息費用
23,49424,44924,82824,73324,50624,58327,34528,91527,39626,458
稅前純益
758
-25,991
-13,447
-12,502
-35,014
-63,162
-35,819
-74,586
-52,662
-71,465
所得稅
726804586172365-1,43133074067176
稅後純益
32
-26,795
-14,033
-12,674
-35,379
-61,731
-36,149
-75,326
-53,333
-71,541
基本每股稅後盈餘(元)
0.00-0.13-0.07-0.06-0.17-0.31-0.19-0.40-0.28-0.38
稀釋每股稅後盈餘(元)
0.00-0.13-0.07-0.06-0.17-0.31-0.19-0.40-0.28-0.38
基本平均股數(千股)
208882.00207381.00206905.00206425.00206064.00201409.00189644.00189118.00188509.00186922.00
稀釋平均股數(千股)
215261.00207381.00206905.00206425.00206064.00201409.00189644.00189118.00188509.00186922.00
還原基本每股稅後盈餘(元)
0.00-0.13-0.07-0.06-0.17-0.31-0.19-0.40-0.28-0.38
還原稀釋每股稅後盈餘(元)
0.00-0.13-0.07-0.06-0.17-0.31-0.19-0.40-0.28-0.38
還原基本平均股數(千股)
208,882207,381206,905206,425206,064201,409189,644189,118188,509186,922
還原稀釋平均股數(千股)
215,261207,381206,905206,425206,064201,409189,644189,118188,509186,922
EBITDA(千元)
23,200-3,9939,6539,058-13,383-41,605-10,651-48,096-26,246-45,570

大家都在看

HOT